Immedica Pharma AB

Immedica Pharma AB is involved in clinical research focused on arginase 1 deficiency (ARG1-D), a rare inherited metabolic disorder affecting the body's ability to process arginine and manage the urea cycle.

• Arginase 1 deficiency (ARG1-D)
• Rare genetic metabolic disease
• Arginine metabolism

The sponsor's research activity is centered on pediatric patients, including children under two years of age, with attention to early-life disease management in a rare enzymatic deficiency.